제형 전문 의약품 수탁개발 및 제조 기업(CDMO) 시장 보고서(2026년)

A pharmaceutical contract development and manufacturing organization (CDMO) for formulations is a company that provides outsourced services for the development and production of drug formulations for pharmaceutical companies. These services include formulation development, analytical testing, clinical trial material production, and large-scale commercial manufacturing.

The main types of dosage forms handled by pharmaceutical CDMOs for formulations include oral solids, oral liquids, injectables, topicals, inhalation products, transdermal patches, and others. Oral solid dosage forms are medications designed for oral administration, formulated to deliver the active drug through the digestive system. These dosage forms are applied across various therapeutic areas, including oncology, cardiology, central nervous system disorders, gastroenterology, infectious diseases, and endocrinology, and are used by multiple end users, including pharmaceutical and biopharmaceutical companies, among others.

Tariffs have impacted the peptide therapeutics contract API manufacturing market by increasing costs for imported reagents, raw materials, and specialized synthesis equipment. Preclinical, clinical, and commercial-scale manufacturing segments are most affected, particularly in North America, Europe, and Asia-Pacific regions such as China and India, which are key suppliers. While tariffs have raised operational costs and slowed supply chains, they have also encouraged local manufacturing, investment in domestic capabilities, and innovation in cost-efficient peptide API production.

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing organization (cdmo) for formulations market statistics, including pharmaceutical contract development and manufacturing organization (cdmo) for formulations industry global market size, regional shares, competitors with a pharmaceutical contract development and manufacturing organization (cdmo) for formulations market share, detailed pharmaceutical contract development and manufacturing organization (cdmo) for formulations market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations industry. This pharmaceutical contract development and manufacturing organization (cdmo) for formulations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market size has grown rapidly in recent years. It will grow from $54.73 billion in 2025 to $60.7 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to limited availability of specialized peptide api manufacturers, reliance on in-house peptide production, growing peptide therapeutics pipelines, increasing regulatory compliance requirements, adoption of basic chemical synthesis methods.

The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market size is expected to see rapid growth in the next few years. It will grow to $90.76 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to advancements in custom peptide synthesis technologies, expansion of commercial-scale gmp manufacturing, increasing outsourcing to cros and smes, development of lifecycle management and process optimization strategies, rising demand for clinical and preclinical peptide api manufacturing. Major trends in the forecast period include rising outsourcing of peptide api manufacturing to contract manufacturers, growth in gmp-grade production for clinical and commercial supply, increasing demand for custom peptide synthesis and purification services, expansion of peptide therapeutics pipelines across pharmaceutical companies, focus on process optimization and lifecycle management for peptide apis.

The growing drug development and manufacturing activities are expected to drive the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in the coming years. Drug development and manufacturing activities refer to the increasing efforts by pharmaceutical and biopharmaceutical companies to research, develop, and produce new drugs. These activities are rising primarily due to the growing global demand for innovative and effective therapeutics, which encourages companies to expand their development pipelines and accelerate manufacturing timelines. Pharmaceutical CDMOs support drug development by optimizing dosage forms, performing stability testing, ensuring regulatory compliance, and managing scale-up and production, enabling faster and cost-efficient product launches. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, up from $393,857 million (€363,300 million) in 2022. Therefore, expanding drug development and manufacturing activities are propelling the growth of the pharmaceutical CDMO for formulations market.

Key companies in this market are focusing on advanced solutions such as biologic formulation platforms to improve drug stability and reduce time-to-market for complex biologic therapies. Biologic formulation platforms are specialized systems designed to create stable, efficient formulations of biologic drugs by optimizing factors such as pH, excipients, and delivery methods to enhance stability, bioavailability, and safety. For instance, in June 2025, WuXi Biologics, a China-based CDMO, launched WuXiHigh 2.0, a next-generation high-concentration formulation platform. This platform enables biologic formulations with protein concentrations up to 230 mg/mL, exceeding the current FDA-approved maximum of 200 mg/mL, while reducing viscosity by up to 90% through proprietary excipients and high-throughput instrumentation. It addresses challenges such as viscosity and aggregation and improves injection efficiency, patient compliance, and manufacturing outcomes across clinical and commercial stages.

In February 2025, Jabil Inc., a US-based provider of engineering, manufacturing, and supply chain solutions, acquired Pharmaceutics International Inc. (Pii) for an undisclosed amount. The acquisition aims to strengthen Jabil's pharmaceutical manufacturing and development capabilities by leveraging Pii's expertise in aseptic filling, lyophilization, and oral solid dose production. Pharmaceutics International Inc. (Pii) is a US-based CDMO that provides formulation development services for injectable and oral drug products, enhancing end-to-end support across clinical and commercial manufacturing.

Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited.

Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market consists of revenues earned by entities by providing services such as analytical and stability testing, formulation development, process development and scale-up, regulatory support and documentation, and commercial-scale manufacturing and packaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market also includes sales of suppositories, ophthalmic preparations, buccal and sublingual tablets, liposomal formulations, and microneedle patches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical contract development and manufacturing organization (cdmo) for formulations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical contract development and manufacturing organization (cdmo) for formulations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Dosage Form: Oral Solids; Oral Liquids; Injectables; Topicals; Inhalation Products; Transdermal And Patches; Other Dosage Forms
• 2) By Therapeutic Area: Oncology; Cardiology; Central Nervous System; Gastroenterology; Infectious Diseases; Endocrinology
• 3) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Users
• Subsegments:
• 1) By Oral Solids: Tablets; Capsules; Granules; Powders; Modified-Release Formulations
• 2) By Oral Liquids: Syrups; Suspensions; Solutions; Emulsions; Elixirs
• 3) By Injectables: Vials; Ampoules; Prefilled Syringes; Lyophilized Injections; Injectable Emulsions
• 4) By Topicals: Creams; Ointments; Gels; Lotions; Foams;
• 5) By Inhalation Products: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizer Solutions; Nasal Sprays; Inhalation Capsules
• 6) By Transdermal And Patches: Matrix Patches; Reservoir Patches; Drug-In-Adhesive Patches; Microneedle Patches; Iontophoretic Patches
• 7) By Other Dosage Forms: Suppositories; Ophthalmic Preparations; Buccal Tablets; Sublingual Tablets; Implants
• Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group; Catalent Inc.; WuXi Biologics; Samsung Biologics; Recipharm AB; Siegfried Holding AG; Evonik Industries AG; Almac Group; Aenova Group; Piramal Pharma Limited; Cambrex; Jubilant Pharmova Limited; CordenPharma; Altasciences; Hovione; Aurigene Pharmaceutical Services Ltd.; DPT Laboratories Ltd.; CARBOGEN AMCIS; Biopharma Group; LGM Pharma; Aarti Pharmalabs Limited.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Outsourcing Of Peptide Api Manufacturing To Contract Manufacturers
  • 4.2.2 Growth In Gmp-Grade Production For Clinical And Commercial Supply
  • 4.2.3 Increasing Demand For Custom Peptide Synthesis And Purification Services
  • 4.2.4 Expansion Of Peptide Therapeutics Pipelines Across Pharmaceutical Companies
  • 4.2.5 Focus On Process Optimization And Lifecycle Management For Peptide Apis

5. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotech Companies
• 5.3 Contract Research Organizations (Cros)
• 5.4 Clinical Research Laboratories
• 5.5 Academic And Research Institutions

6. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Segmentation

• 9.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms
• 9.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology
• 9.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users
• 9.4. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Solids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets, Capsules, Granules, Powders, Modified-Release Formulations
• 9.5. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Oral Liquids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Syrups, Suspensions, Solutions, Emulsions, Elixirs
• 9.6. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Injectables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions
• 9.7. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Topicals, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Creams, Ointments, Gels, Lotions, Foams
• 9.8. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Inhalation Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules
• 9.9. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Transdermal And Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches
• 9.10. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants

10. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regional And Country Analysis

• 10.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 11.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 12.1. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 13.1. India Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 14.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 15.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 16.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 17.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 18.1. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 19.1. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 20.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 21.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 22.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 23.1. France Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 24.1. Italy Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 25.1. Spain Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 26.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 27.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 28.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 29.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 30.1. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 31.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 32.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 33.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

• 34.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market, Segmentation By Dosage Form, Segmentation By Therapeutic Area, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Regulatory and Investment Landscape

36. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Catalent Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. WuXi Biologics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Samsung Biologics Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Other Major And Innovative Companies

• Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group

38. Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market

40. Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer